These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1702005)

  • 41. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
    Borsos T; Circolo A
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():5-9. PubMed ID: 6587743
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Terminal stages of complement hemolysis: technical comment.
    Wirtz GH; Westfall SS
    Immunol Lett; 1981 Apr; 3(1):51-5. PubMed ID: 6792060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the membrane attack complex of complement an enzyme?
    Boyle MD
    Mol Cell Biochem; 1984; 61(1):5-15. PubMed ID: 6369113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R; Erdtmann K
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
    Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetics of bovine complement. II. Properties of the lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):34-40. PubMed ID: 4997115
    [No Abstract]   [Full Text] [Related]  

  • 48. Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.
    Pickering RJ; Wolfson MR; Good RA; Gewurz H
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):521-7. PubMed ID: 4978744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of bovine complement. I. Formation of a lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):28-33. PubMed ID: 5091959
    [No Abstract]   [Full Text] [Related]  

  • 51. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ca2+-activated K+ efflux limits complement-mediated lysis of human erythrocytes.
    Halperin JA; Brugnara C; Nicholson-Weller A
    J Clin Invest; 1989 May; 83(5):1466-71. PubMed ID: 2708520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement lysis of resealed red cell membrane ghosts pretreated with glutaraldehyde.
    Giavedoni EB; Chow YM; Dalmasso AP
    J Immunol; 1979 May; 122(5):1643-8. PubMed ID: 109512
    [No Abstract]   [Full Text] [Related]  

  • 54. ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS.
    NUSSENZWEIG RS; MERRYMAN C; BENACERRAF B
    J Exp Med; 1964 Aug; 120(2):315-28. PubMed ID: 14206442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the in vitro ageing on the restriction of sheep erythrocyte lysis by horse serum.
    Assis AI; Pereira G; Azzolini AE; Barbosa JE
    Scand J Immunol; 1991 May; 33(5):579-84. PubMed ID: 2031148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyanine dye fluorescence used to measure membrane potential changes due to the assembly of complement proteins C5b-9.
    Wiedmer T; Sims PJ
    J Membr Biol; 1985; 84(3):249-58. PubMed ID: 4032456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents.
    KLEIN PG
    J Exp Med; 1960 Jan; 111(1):77-91. PubMed ID: 13848490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage.
    Frank MM; Dourmashkin RR; Humphrey JH
    J Immunol; 1970 Jun; 104(6):1502-10. PubMed ID: 5452415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.